Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation

JR Crosby, WE Kaminski, G Schatteman… - Circulation …, 2000 - Am Heart Assoc
Granulation tissue formation is an example of new tissue development in an adult. Its rich
vascular network has been thought to derive via angiogenic sprouting and extension of …

IMPROvE-CED trial: intracoronary autologous CD34+ cell therapy for treatment of coronary endothelial dysfunction in patients with angina and nonobstructive …

MT Corban, T Toya, D Albers, F Sebaali… - Circulation …, 2022 - Am Heart Assoc
Background: Coronary endothelial dysfunction (CED) causes angina/ischemia in patients
with nonobstructive coronary artery disease (NOCAD). Patients with CED have decreased …

Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up

AJ Boyle, R Whitbourn, S Schlicht, H Krum… - International journal of …, 2006 - Elsevier
Current stem cell protocols for ischemic heart disease are limited by the small numbers of
cells that can be obtained by bone marrow aspirate. To increase myocardial delivery of bone …

Coexpression of endothelial markers and CD14 by cytokine mobilized CD34+ cells under angiogenic stimulation

D Nakul-Aquaronne, J Bayle… - Cardiovascular research, 2003 - academic.oup.com
Objective: A subset of adult peripheral blood leukocytes functions as endothelial progenitor
cells that incorporate into the vasculature in animal models of neovascularization. The basic …

Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral …

V Subramaniyam, EK Waller, JR Murrow… - American heart …, 2009 - Elsevier
BACKGROUND: We hypothesized that granulocyte macrophage colony-stimulating factor
(GM-CSF) administration will be safe and will improve endothelial dysfunction and exercise …

Regarding “Isolation of endothelial cells and their progenitor cells from human peripheral blood”

A Tiwari, G Hamilton, AM Seifalian… - Journal of vascular …, 2002 - jvascsurg.org
We are writing in regard to your published article “Isolation of endothelial cells and their
progenitor cells from human peripheral blood”(J Vasc Surg 2000; 31: 181-9). We read with …

[HTML][HTML] CD34-positive stem cells in the treatment of heart and vascular disease in human beings

AR Mackie, DW Losordo - Texas Heart Institute Journal, 2011 - ncbi.nlm.nih.gov
Bone marrow-derived CD34+ cells are a well-characterized population of stem cells that
have traditionally been used clinically to reconstitute the hematopoietic system after …

Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated …

A Hirsch, R Nijveldt, PA van der Vleuten… - European heart …, 2011 - academic.oup.com
Aims Previous trials that investigated cell therapy as an adjunctive therapy after acute
myocardial infarction (AMI) have shown conflicting results. We designed a randomized …

Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease

T Eizawa, U Ikeda, Y Murakami, K Matsui, T Yoshioka… - Heart, 2004 - heart.bmj.com
METHODS Thirty four patients (mean (SEM) age 62.5 (1.7) years) with angiographically
documented stable CAD, and 36 healthy control subjects (mean (SEM) age 53.6 (2.0) years) …

Circulating stromal osteonectin-positive progenitor cells and stenotic coronary atherosclerosis

ZA Gabbasov, AA Agapov, OS Saburova… - Canadian journal of …, 2007 - cdnsciencepub.com
The level of circulating stromal progenitor cells carrying osteonectin (ON), a marker of
osteogenic differentiation, was evaluated by flow cytometry in blood of patients with coronary …